ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 294 participants.

Also called NCT04061798

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 294 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04061798
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Netherlands (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04061798. Randomized; single masking; primary purpose treatment. Start 2020-03-02 (actual); primary completion 2024-04-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.
Acronym
ACTION-1
Condition
Abdominal Aortic Aneurysm
Condition
Surgery
Condition
Arterial Disease
Intervention (Drug)
ACT guided heparinization
Intervention (Drug)
5 000 IU of heparin
Lead sponsor
Dijklander Ziekenhuis (class: other)
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (class: other)
Collaborator
Amsterdam UMC, location VUmc (class: other)
Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (class: other)

Record details

Record id
cardio:ct-nct04061798
Content hash
c24f2eb21aa7e07370990dfa529585bfef31105d07d367b54ba8ca07e1427ada